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CONCISE COMMUNICATION 
Pathogenesis of Human and Bovine Cryptosporidium parvum 
in Gnotobiotic Pigs 
Sonia J. Pereira,1'2 Norma E. Ramirez,1'2 Lihua Xiao,3 
and Lucy A. Ward1'2 
lFood Animal Health Research Program, Ohio Agricultural Research 
and Development Center, and 2Department of Veterinary Preventive 
Medicine, College of Veterinary Medicine, Ohio State University, 
Wooster; 3Immunology Branch, Division of Parasitic Diseases, Centers 
for Disease Control and Prevention, Atlanta, Georgia 
To compare the pathogenesis of human genotype 1 (HuGl) and bovine genotype 2 (BoG2) 
Cryptosporidium parvum, neonatal gnotobiotic pigs were given 1-10 HuGl or BoG2 oocysts. 
The prepatent and patent periods were significantly longer for HuGl than for BoG2 C parvum 
(prepatent, 8.6 vs. 5.6 days; patent, 16.6 vs. 10.3 days). BoG2-infected pigs developed signif- 
icantly more severe disease than did HuGl-infected pigs. BoG2 parasites were seen micro- 
scopically throughout the intestines during the prepatent and patent periods. HuGl parasites 
were only detected during the patent period in the ileum and colon but colonized the mucosal 
surface in significantly larger numbers than did BoG2. Moderate-to-severe villus/mucosal 
attenuation with lymphoid hyperplasia was seen throughout the intestines of BoG2-infected 
pigs, whereas lesions in HuGl-infected pigs were mild to moderate and restricted to the ileum 
and colon. These findings provide additional support for the hypothesis that human and 
bovine C. parvum genotypes may be separate species. 
Cryptosporidium parvum causes acute infectious diarrhea in 
humans and animals worldwide. Molecular studies have iden- 
tified at least 2 major genotypes within human-pathogenic C. 
parvum: human genotype 1 (HuGl) and bovine genotype 2 
(BoG2). These genotypes have biological differences in terms 
of host range; BoG2 isolates appear to be infectious for a wide 
variety of mammalian species, whereas HuGl isolates appear 
to be highly selective, infecting principally humans [1]. This 
difference is important, because most human cases of crypto- 
sporidiosis ^750Zo) are caused by HuGl; ^507o are caused by 
BoG2 [1, 2]. 
The biological behavior of BoG2 C. parvum has been studied 
in several animal models, including the gnotobiotic pig [3-7], 
and can be defined by time to onset of oocyst shedding, or 
prepatent period; duration of shedding, or patent period; and 
severity of disease and pathologic lesions. The prepatent periods 
of BoG2 isolates in calves [5], mice [6], pigs [3], and humans 
[7] vary considerably. BoG2-infected calves and gnotobiotic 
pigs typically show symptoms of moderate-to-severe diarrhea 
with weight loss and sometimes death due to dehydration and 
wasting. The biological behavior of HuGl C parvum in animals 
has not been studied until now because of the parasite's inability 
to infect nonhuman hosts. However, longitudinal studies in 
humans suggest that the human and bovine genotypes behave 
differently in the human host [8, 9]. 
High doses (thousands to millions of oocysts) of BoG2 C. 
parvum are traditionally used in animal pathogenesis studies, 
although most naturally acquired Cryptosporidium infections 
result from ingestion of relatively few oocysts. In fact, the risk 
of C parvum infection is heightened as a result of the parasite's 
low infective dose. The recent finding that HuGl isolates can 
infect neonatal gnotobiotic pigs [3, 4] has made possible com- 
parative studies on the biological behavior of HuGl and BoG2 
C parvum in a single host species. We believe that the present 
study is the first to compare the clinical and pathologic outcome 
of HuGl and BoG2 C parvum infections by using small num- 
bers of oocysts (1-10 oocysts) to better emulate naturally ac- 
quired infections. 
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Methods 
BoG2 C. parvum GCH1 was supplied to our laboratory by S. 
Tzipori (Tufts University, School of Veterinary Medicine, Grafton, 
MA). GCH1 was first isolated from a patient with AIDS and was 
subsequently maintained by passage in neonatal calves. HuGl C 
parvum H2132 and H2265 were obtained from persons infected in 
waterborne disease outbreaks in South Carolina and Nebraska, 
respectively. Each C. parvum isolate was serially passaged in gno- 
tobiotic oies and confirmed to be BoG2 or HuGl before and after 
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selected pig passages by nested polymerase chain reaction restric- 
tion fragment-length polymorphism (RFLP) targeting the small 
subunit rRNA gene [10]. 
For the first pig passage, day-old gnotobiotic pigs were fed 103 
and 105 oocysts extracted from infected calf or human feces by 
immunomagnetic beads (1MB) (Dynabeads Anti-Cryptosporidium 
[no. 730.01]; Dynal). Pigs were euthanized 24-48 h after the de- 
tection of oocyst shedding by acid-fast stain and UV light mi- 
croscopy [11], and their intestinal contents were collected and stored 
at 40C. For subsequent passages, oocysts were extracted from pig 
intestinal contents by 1MB and counted by hemocytometer. Sterile 
water was added to create a suspension of 103 oocysts/mL, and a 
5-juL droplet of each oocyst suspension was then placed on a drop 
slide and examined microscopically (X400 magnification). Droplets 
with 1-10 oocysts were covered with 50 juL of Wo low-melting- 
point agarose (Life Technologies) and fed to pigs within 1 h. In 
the present study, 1-10 oocysts from the intestinal contents of the 
third (for strain H2132) and fifth (for strains GCH1 and H2265) 
pig passages were isolated as described and fed to pigs. 
Forty gnotobiotic pigs were derived and maintained as described 
elsewhere [12]. At age 1 day, 15 pigs were fed 1-10 HuGl oocysts, 
15 pigs were fed 1-10 BoG2 oocysts, and 10 pigs were fed agarose. 
Pigs were monitored daily for clinical disease and oocyst shedding 
by acid-fast stain and UV light microscopy [11]. Feces were ex- 
amined and scored as follows: 0, normal; 1, pasty; 2, opaque liquid; 
and 3, watery. Diarrhea was considered to be present at scores ̂ 2. 
Dehydration was described as mild (visible vertebrae), moderate 
(prominent vertebrae and eyes retracted in orbit ̂  mm), and severe 
(prominent protruding vertebral and pelvic bones and eyes re- 
tracted in orbit ̂  mm). 
Three pigs from each infected group and 2 uninfected control 
pigs were killed 3 days after inoculation (DAI) and 0, 7, 21, and 
42 days after onset (DAO) of oocyst shedding. Intestinal contents 
from each pig were collected and stored at 40C. Sections of duo- 
denum, jejunum, ileum, and colon were collected as described else- 
where [13], placed in fixative (Prefer; Anatech) for 24-48 h, pro- 
cessed through graded alcohols, embedded in paraffin, sectioned 
at 4 jitm, and stained with hematoxylin-eosin (HE). 
Slides were coded and examined by an examiner who had no 
knowledge of infecting genotype or strain. The average intestinal 
infection rate per 100 linear micrometers in 10 random fields per 
intestinal section was evaluated at X400 magnification and scored 
as follows: 0, no parasites detected; 1, 1-10 parasites/100 jum; 2, 
11-30 parasites/100 fim; and 3, ̂ 0 parasites/100 fim. Villus height 
and width, crypt height and width, and epithelial cytoplasmic vac- 
uolation at villus tips were used to determine the extent of mucosal 
attenuation and were scored as follows: 0, same as in control pigs; 
1, mild; 2, moderate; and 3, severe. The extent to which lymphoid 
cells had infiltrated the submucosa and the lamina propria and the 
size of organized submucosal lymphoid follicles (i.e., Peyer patches) 
determined the extent of lymphoid hyperplasia and was scored as 
follows: 0, same as in control pigs; 1, mild; 2, moderate; and 3, 
marked. 
Between-group differences in mean diarrhea scores, dehydration, 
and prepatent and patent periods were identified by the general 
linear model (SAS Institute). We used x2 analysis to compare data 
Figure 1. Photomicrographs show peak oocyst infection rates in ileum (A and B) villus attenuation in small intestine (C and D), and lymphoid 
hyperplasia in cecum (E and F) tissues from gnotobiotic pigs infected with bovine (A, C, and E) or human (B, D, and F) Cryptosporidium parvum 
(hematoxylin-eosin stain; original magnifications, X400 [A and B] and X25 [C-Fl). 
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Table 1. Mean scores for pathologic lesions in the duodenum (D), jejunum (J), ileum (I), and colon (C) 
of gnotobiotic pigs infected with human and bovine Cryptosporidium parvum. 
Human 
3 Days after inoculation 0 0 0 0 0 0 0 0 0 0 0 0 
Days after onset 
0 0 0 2.3 1.7 0 0 1 1 0 0 1 1 
7 0 0 2 1.7 0 0 1 1 0 0 1 1 
21 0 0 0 1 0 0 1.5 1 0.7 1 1 0.1 
42 0 0 1 0 0 0 1.6 1 0 0 1 0 
Bovine 
3 Days after infection 1 0 0 0 1 0 0.7 0 0.1 0 0 0 
Days after onset 
0 1 0.3 0.3 1 1.7 1 1 1 1.1 1 0 1 
7 1.3 0.7 1.3 1 1 1.5 1.5 1.5 1.1 1 1 0.5 
21 0 0 1 0.3 1 1 1 2 1 0.5 1 2 
42 0 0 0 0 1 1 1.3 1.3 0 0 0 0 
NOTE. For each C. parvum genotype, 3 pigs were infected. 
d Score: 0, no parasites detected; 1, 1-10 parasites/100 /xm; 2, 11-30 parasites/100 /mi; 3, ^0 parasites/100 /mi. b b Score: 0, same as control pigs; 1, mild; 2, moderate; 3, marked. 
c Score: 0, same as control pigs; 1, mild; 2, moderate; 3, severe. 
for pathologic lesions between groups. P ^ .05 was considered to 
be significant. 
Results 
The prepatent period for HuGl-infected pigs was signifi- 
cantly longer (mean ? SE, 8.6 ? 0.5 days) than for BoG2-in- 
fected pigs (5.6 ? 0.6 days) {P = .001). HuGl-infected pigs 
shed oocysts for 16.6 ? 1.8 days, whereas BoG2-infected pigs 
shed oocysts for 10.3 ? 1.7 days {P = .03). In the first week 
after the onset of shedding, HuGl-infected pigs had daily fecal 
scores of 1.8 ? 0.16, and BoG2-infected pigs had significantly 
higher daily fecal scores of 2.6 ? 0.14 (P = .009). Daily fecal 
scores of control pigs were 0.48 ?0.8. During the patent period, 
BoG2-infected pigs developed moderate-to-severe dehydration 
and weight loss, whereas HuGl-infected pigs showed mild-to- 
no dehydration or weight loss in comparison with control pigs. 
Microscopic examination of HE-stained tissue sections re- 
vealed BoG2 parasites in the duodenum, jejunum, ileum, and 
colon (figure \A). BoG2 parasites were detected in the intestinal 
tissues of pigs killed during the prepatent (3 DAI) and patent 
(0-21 DAO) periods. However, HuGl parasites were only seen 
during the patent period in the ileum and colon. No HuGl 
parasites were detected in the duodenum and jejunum at any 
time during the study (table 1). Significantly more HuGl par- 
asites than BoG2 parasites were observed per villus in the ileum 
(P = .05) at 0 DAO (figure \A and \B). 
Moderate lymphoid hyperplasia was seen at 0 DAO in the 
duodenum, at 7 DAO in the jejunum and ileum, and at 7 and 
21 DAO in the colon of BoG2-infected pigs (table 1 and figure 
\E). Other intestinal sections showed mild lymphoid hyperpla- 
sia and infiltration of scattered neutrophils. Lymphoid hyper- 
plasia in the HuGl-infected pigs was noted only during the 
patent period. Mild lymphocytic infiltrates and rare inflam- 
matory cells were seen at this time in the ileum and colon only 
(table 1 and figure \F). The difference between the mean lym- 
phoid hyperplasia scores for the 2 genotypes in the duodenum 
(P = .002), jejunum (P = .02), ileum (P = .02), and colon 
(P = .008) during the patent period was statistically significant. 
Mild and moderate villus attenuation with epithelial slough- 
ing was seen at 0 DAO and 7 DAO in the duodenum and at 
21 DAO in the colon of BoG2-infected pigs (table 1). All other 
intestinal sections showed only mild villus attenuation between 
3 DAI and 21 DAO. Comparatively few HuGl-infected pigs 
showed mild villus/mucosal attenuation during the patent pe- 
riod, and attenuation was restricted to the ileum and colon 
(0-21 DAO; figure 1C and ID). The difference between the 
mean villus attenuation scores for the 2 genotypes in the du- 
odenum (P = .007), jejunum (P = .04), and ileum (P = .02) 
during the patent period was statistically significant. 
Discussion 
Infection of day-old gnotobiotic pigs with ^10 HuGl or 
BoG2 oocysts resulted in extensive parasite colonization and 
disease. It has been suggested that serial passages in a host may 
increase virulence, with ingestion of lower doses achieving 
higher infection rates and more-severe disease in young gno- 
tobiotic pigs [3]. Our findings suggest otherwise: the minimum 
infective dose of each isolate for gnotobiotic pigs was a single 
oocyst, after the first pig passage. In addition, the 8-9- and 
5-6-day prepatent periods of HuGl and BoG2 isolates in gno- 
tobiotic pigs were evident after the first passage and remained 
so after several additional passages. The HuGl isolates also 
elicited minimal disease in all subsequent passages, whereas the 
BoG2 isolate elicited moderate-to-severe disease accompanied 
by loss of weight that often was not regained. Examination of 
intestines from pigs in these early and subsequent serial pas- 
Genotype, time point 
Parasite burdena 
DJ IC 
Lymphoid hyperplasia15 
DJ IC 
Villus attenuation0 
DJ IC 
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sages revealed parasite infection rates, parasite tissue distri- 
bution, and pathologic lesions similar to those described in the 
present study (L.A.W., unpublished data). 
Preliminary studies of 2 other BoG2 and 3 other HuGl iso- 
lates in gnotobiotic pigs similarly have shown that all BoG2 
strains have shorter prepatent periods (3-6 vs. 8-12 days) and 
have elicited more disease than HuGl strains (L.A.W., unpub- 
lished data). Thus, the clinical outcome of a C. parvum infection 
in gnotobiotic pigs appears to be determined in part by the 
genotype of the parasite, and serial low-dose passage of the C. 
parvum used in this study did not significantly alter the strain 
virulence for gnotobiotic pigs. 
HuGl-infected pigs had significantly more parasites in the 
ileum than did the BoG2-infected pigs, yet HuGl-associated 
intestinal lesions were only mild to moderate, compared with 
BoG2-associated lesions. This apparent discrepancy between 
infection intensity and lesion severity may be the result of 
unique parasite virulence factors yet to be identified. Differences 
in the host's immune response to each genotype may also con- 
tribute to the observed discrepancy. 
We have demonstrated elsewhere that a strong time-depen- 
dent correlation exists between intestinal mucosal cytokine re- 
sponses, disease onset, intestinal pathology, disease resolution, 
and parasite clearance in BoG2-infected pigs [3]. The immune 
response to BoG2 parasites may limit parasite load and elim- 
inate infection sooner but simultaneously contribute to pa- 
thology and disease, whereas the absence of such a response 
would permit greater parasite replication for a longer period 
of time, with minimal pathology, as was observed in HuGl- 
infected pigs in the present study. Comparative studies of the 
gnotobiotic pig's cytokine and antibody responses to BoG2 and 
HuGl C parvum isolates are under way. 
The observed differences between tissue colonization sites for 
HuGl and BoG2 C parvum also may help to explain the dif- 
ferences seen in the clinical outcome of infection in the same 
host species. BoG2 C. parvum colonized the entire small intes- 
tine (duodenum, jejunum, and ileum) and colon, whereas HuGl 
C. parvum colonized only the ileum and colon. Because the 
upper small intestine is important in regulating absorption of 
nutrients and electrolytes, hindrance of its function often leads 
to a malabsorptive diarrhea. We noted a loss in epithelial in- 
tegrity and villus attenuation of the small intestine, which was 
associated with the presence of parasites within the epithelial 
brush border and moderate-to-severe clinical disease in BoG2- 
infected pigs. Thus, we propose that the colonization site of 
the parasite within the host is a determinant of disease ex- 
pression by that host. A clinical case study in patients with 
AIDS who had a history of cryptosporidiosis showed that dif- 
ferent anatomic locations of the parasite produced different 
disease outcomes [14]. 
In conclusion, HuGl and BoG2 C. parvum were identified 
by RFLP and used to infect gnotobiotic pigs. During sequential 
low-dose passages, these isolates showed distinctly different bio- 
logical behaviors in the pig host, in terms of prepatent and patent 
periods, disease severity, pathology, and tissue colonization sites, 
that correlated with the strain's genotype. Given the increas- 
ingly significant molecular and biological differences between 
these genotypes that are being identified, reexamination and 
redefinition of the Cryptosporidium taxa may be in order. 
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